Albireo — funding rounds & investors · Tech.eu Funding Explorer
Albireo
Exited
Provider of bile-acid modulators to treat pediatric and adult cholestatic liver diseases.
Albireo is tracked in the Tech.eu funding database. Based in Boston, United States; active in Healthtech. Acquired by Ipsen in 2023. Data as of 27 Aug 2026.
